A few of these (regions associated with ADAMTS1, SCARF2, and DSCR9) were tested further, and in combination, showed ~100% sensitivity and ~85% specificity for prostate cancer compared to matched adjacent benign tissues. The gene discussed is DSCR9; the disease is Familial prostate cancer.